NEU 3.50% $14.05 neuren pharmaceuticals limited

TROFINETIDE TRIALS UPDATE, page-76

  1. 761 Posts.
    lightbulb Created with Sketch. 83
    Only half of them have had the drug at that point. They could have had no effect and want to do Lilac to make sure they are getting the drug.

    Plenty of scenarios why patients might want to continue. I don’t think we can infer much from sites enrolling other than a sign that at least one of those patients has compelled the first stage.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.